Carregant...
Immunomodulatory Drugs Regulate HMGB1 Release from Activated Human Monocytes
Several HMGB1-specific antagonists have provided beneficial results in multiple models of inflammatory disease–preclinical trials including arthritis. Since no HMGB1-specific targeted therapy has yet reached the clinic, we have performed in vitro studies to investigate whether any of a selection of...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
ScholarOne
2010
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2935946/ https://ncbi.nlm.nih.gov/pubmed/20386869 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2010.00031 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|